Gemfibrozil Tablet
Product Images NDC 70771-1431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 70771-1431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 01)

Structure (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 01)
Chemical structure diagram of gemfibrozil showing the arrangement of carbon, hydrogen, and oxygen atoms in the molecule.*
FDA Label Image

Label (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 02)

Label (Fddf5419 1b09 40bf 9aea 3cd4893d92ae 02)
Label for Gemfibrozil Tablets, USP 600 mg oral tablets by Zydus Pharmaceuticals. The label states each film-coated tablet contains 600 mg gemfibrozil. It includes storage instructions, warnings to keep out of reach of children, and manufacturer information listing Cadila Healthcare Ltd., Ahmedabad, India. The package contains 30 tablets and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.